Natural varicella-zoster virus reactivation shortly after varicella immunization in a child

Pediatric Infectious Disease Journal

Volumn 18, Issue 12, 1999, Pages 1112-1113

  Kohl, Steve ^a   Rapp, Jonathan ^a   La Russa, Phillip ^b   Gershon, Anne A ^b   Steinberg, Sharon P ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Columbia Univ Coll Phys Surgs ^*  (United States)

Author keywords

Varicella immunization; Varicella zoster virus; Zoster

Indexed keywords

CHICKENPOX VACCINE; ETHIDIUM BROMIDE; IBUPROFEN; PROCHLORPERAZINE; RESTRICTION ENDONUCLEASE;

ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; DISEASE COURSE; FEVER; GASTROINTESTINAL TOXICITY; HUMAN; MALE; PAIN; PRIORITY JOURNAL; RASH; VARICELLA ZOSTER VIRUS; VIRUS CULTURE; VIRUS REACTIVATION;

EID: 0032784810     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199912000-00023     Document Type: Article

References (20)

1. Guess HA, Broughton DD, Melton LJ, Kurland, LT. Epidemiology of herpes zoster in children and adolescents: a population-based study. Pediatrics 1985;76:512-7.
2. Smith CG, Glaser DA. Herpes zoster in childhood: case report and review of the literature. Pediatric Dermatol 1996;13: 226-9.
3. Pertursson G, Helgarson S, Gudmunsson S, Sigurdsson JA. Herpes zoster in children and adolescents. Pediatr Infect Dis J 1998;17:905-8.
4. Baba K, Yabuuchi H, Takahashi M, Ogra PL. Increased incidence of herpes zoster in normal children infected with varicella zoster virus during infancy: community-based follow-up study. J Pediatr 1986;108:372-7.
5. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices, July 12, 1996. MMWR 1996;45:1-32.
6. LaRussa P, Lungu O, Hardy I, Gershon A, Steinberg S, Silverstein S. Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates. J Virol 1992;66:1016-20.
7. LaRussa P, Steinberg S, Sharrar R, Galea S, Gershon A. Identification and differentiation of wild (WT)-and vaccine (OKA)-strain VZV isolates by PCR from recipients of live attenuated varicella vaccine (LAVV) [Abstract P-49]. Presented at the Third International Conference on the Varicella-Zoster Virus, Palm Beach, FL, March 10, 1997.
8. White CJ. Clinical trials of varicella vaccine in healthy children. Infect Dis Clin North Am 1996;10:595-608.
9. Na GY. Herpes zoster in three healthy children immunized with varicella vaccine (Oka/Biken): the causative virus differed from vaccine strain on PCR analysis of the IV variable region (R5) and of a PstI-site region. Br J Dermatol 1997;137:255-8.
10. Liang MG, Heidelberg KA, Jacobson RM, McEvoy MT. Herpes zoster after varicella immunization. J Am Acad Dermatol 1998;38:761-3.
11. Christensen CL, Poulsen A, Bottiger B, Kirk M, Andersen HK, Schmiegelow K. Complications in two children with acute lymphatic leukemia caused by vaccination against varicella zoster virus. Ugeskr Laeger 1999;161:794-6.
12. Gershon AA, LaRussa P, Steinberg S, Mervish N, Lo SH, Meier P. The protective effect of immunologic boosting against zoster: an analysis in leukemic children who were vaccinated against chickenpox. J Infect Dis 1996;173:450-3.
13. Hammerschlag MR, Gershon A, Steinberg S, Clarke L, Gelb L. Herpes zoster in an adult recipient of live attenuated varicella vaccine. J Infect Dis 1989;160:535-7.
14. Brunell PA, Taylor-Wiedeman J, Geiser C, Frierson L, Lydick E. Risks of herpes zoster in children with leukemia: varicella vaccine compared with history of chickenpox. Pediatrics 1986;77:53-6.
15. Lawrence R, Gershon AA, Holzman R, Steinberg SP. The risk of zoster after varicella vaccination in children with leukemia. N Engl J Med 1988;318:543-8.
16. Hardy I, Gershon AA, Steinberg SP, La Russa P. The incidence of zoster after immunization with live attenuated varicella vaccine: a study in children with leukemia. N Engl J Med 1991;325:1545-50.
17. Broyer M. Tete MJ, Guest G, Gagnadoux MF, Rouzioux C. Varicella and zoster in children after kidney transplantation: long-term results of vaccination. Pediatrics 1997;99:35-9.
18. Garnett GP, Grenfell BT. The epidemiology of varicella-zoster virus infections: the influences of varicella on the prevalence of herpes zoster. Epidemiol Infect 1992;108:513-28.
19. Terada K, Kawano S, Yoshihiro K, Morita T. Varicella-zoster virus (VZV) reactivation is related to the low response of VZV-specific immunity after chickenpox in infancy. J Infect Dis 1994;169:650-2.
20. Levin MJ, Barber D, Goldblatt E, et al. Use of a live attenuated varicella vaccine to boost varicella-specific immune response in seropositive people 55 years of age and older: duration of booster effect. J Infect Dis 1998:178(Suppl 1):S109-12.